1. Home
  2. LCNB vs ARMP Comparison

LCNB vs ARMP Comparison

Compare LCNB & ARMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LCNB Corporation

LCNB

LCNB Corporation

N/A

Current Price

$19.47

Market Cap

223.1M

Sector

Finance

ML Signal

N/A

Logo Armata Pharmaceuticals Inc.

ARMP

Armata Pharmaceuticals Inc.

N/A

Current Price

$4.40

Market Cap

199.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LCNB
ARMP
Founded
1877
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
223.1M
199.7M
IPO Year
1999
1996

Fundamental Metrics

Financial Performance
Metric
LCNB
ARMP
Price
$19.47
$4.40
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$15.00
AVG Volume (30 Days)
23.0K
74.7K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
5.43%
N/A
EPS Growth
68.04
N/A
EPS
0.84
N/A
Revenue
$6,445,000.00
N/A
Revenue This Year
$8.50
N/A
Revenue Next Year
$3.66
N/A
P/E Ratio
$22.75
N/A
Revenue Growth
N/A
N/A
52 Week Low
$14.31
$2.88
52 Week High
$21.32
$14.98

Technical Indicators

Market Signals
Indicator
LCNB
ARMP
Relative Strength Index (RSI) 49.57 54.05
Support Level $19.01 $3.98
Resistance Level $20.48 $5.63
Average True Range (ATR) 0.47 0.52
MACD -0.04 0.01
Stochastic Oscillator 51.62 41.37

Price Performance

Historical Comparison
LCNB
ARMP

About LCNB LCNB Corporation

LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Share on Social Networks: